P-041 - SAFETY, TOLERABILITY AND PHARMACOKINETICS OF SINGLE INTRAVENOUS ADMINISTRATIONS OF SODIUM TAURODEOXYCHOLATE (HY209), A NOVEL CANDIDATE FOR SEPSIS TREATMENT.
W. Chung1, I. Jeon2, B. Kim2, Y. Park2, S. Seoung2,3,4, S. Han5, K. Yu2, S. Yoon6, I. Jang2; 1Seoul National University, Seoul, South Korea, 2Seoul National University, Seoul, Republic of Korea, 3Wide River Institute of Immunology, Seoul National University, Seoul, Republic of Korea, 4Shaperon Inc, Seoul, Republic of Korea, 5Shaperon, Inc., Seoul, Republic of Korea, 6Seoul National University, Gyeonggi-do, Republic of Korea.
.jpg "Woo Kyung Chung, MD photo")
.png)